Manulife IncomeBoost: A Whole Life Plan Focused on Monthly Cash Flow

Manulife IncomeBoost is a regular-premium participating whole life insurance plan designed to provide policyholders with a steady stream of monthly income rather than just a lump-sum death benefit. Launched in September 2025, this product allows the life insured to receive guaranteed and non-guaranteed monthly payouts starting from the 49th policy monthiversary until the maturity date (the policy anniversary immediately after the life insured’s 120th birthday). The plan features a flexible premium payment term ranging from 2 to 5 years. A key differentiator is its "No Underwriting Required" feature, which simplifies the application process for eligible applicants. While it offers death and terminal illness coverage, along with a waiver of premium on total and permanent disability (TPD) and a specific terminal cancer benefit, it does not allow payments via SRS or CPFIS. The plan’s performance is linked to Manulife’s participating fund, which has reported a 3-year net investment return of 3.63%, though longer-term data is currently unavailable.

How it compares

When evaluating Manulife IncomeBoost against similar whole life income plans on CompareFIRST.sg (data as of July 2026), distinct trade-offs emerge regarding cost, surrender value, and fees. All figures below are standardized per $100,000 sum assured for comparability.

Premium Costs Manulife IncomeBoost carries a relatively high annual premium of $33,300. In comparison, FWD Life Income Plus is significantly more affordable at $10,000 per year, though it requires a longer premium payment term (6 to 10 years vs. Manulife’s 2 to 5 years). PRULifetime Income Plus (RP) sits in the middle at $25,000, while TM Retirement GIO Plus (II) is priced at $31,865, making it slightly cheaper than Manulife but with a higher age entry point (40 vs. 35).

Surrender Values at Year 20 The most striking difference lies in the projected surrender value after 20 years. TM Retirement GIO Plus (II) offers a substantially higher surrender value of $163,770, nearly double that of Manulife’s $100,000. FWD Life Income Plus is very close to Manulife at $103,038, while PRULifetime Income Plus (RP) is slightly lower at $99,300. This suggests that for consumers prioritizing cash value accumulation over time, TM Retirement GIO Plus may be more efficient.

Expenses and Returns Manulife IncomeBoost has a Total Expense Ratio (TER) of 2.40% at the 5-year mark. This is higher than TM Retirement GIO Plus (II)’s low TER of 0.58%, but lower than PRULifetime Income Plus (RP)’s 2.27% (note: PRU's TER is listed as 2.27% in the table, which is actually lower than Manulife's 2.40%, so Manulife is more expensive here). Regarding returns, TM Retirement GIO Plus (II) and PRULifetime Income Plus (RP) both provide illustrated net returns for 5 and 10-year periods (up to 4.16% and 3.95% respectively), whereas data for Manulife’s 5/10-year net return is not available in the comparison table, though its 3-year return stands at 3.63%.

Pros

• No Underwriting Required: Simplifies the application process, making it accessible for those who may have difficulty with medical underwriting.
• Regular Income Stream: Provides a predictable cash flow via monthly payouts starting early in the policy term (49th month).
• Strong Insurer Rating: Backed by Manulife’s strong credit ratings (AA- by S&P/Fitch, A1 by Moody's), indicating financial stability.
• Terminal Cancer Benefit: Includes a specific benefit paying 20% of the annual premium upon diagnosis of terminal cancer, subject to limits.

Cons

• High Premium Cost: At $33,300 per year (per $100k SA), it is one of the most expensive options in its peer group.
• Lower Surrender Value: The Year 20 surrender value ($100,000) is significantly lower than competitors like TM Retirement GIO Plus ($163,770).
• Limited Payment Options: Does not accept SRS or CPFIS premium payments, limiting funding flexibility for some Singaporeans.
• Missing Long-Term Return Data: The comparison table does not provide 5-year or 10-year net investment return data for Manulife IncomeBoost, making long-term performance verification difficult compared to peers with published rates.

Who it may suit

Manulife IncomeBoost may suit individuals who prioritize immediate cash flow and ease of entry (via no underwriting) over long-term capital accumulation or low premiums. It is ideal for those who do not wish to use CPFIS or SRS funds and are comfortable with a higher annual premium in exchange for the convenience of simplified application and regular monthly income. However, consumers seeking higher surrender values or lower costs might find TM Retirement GIO Plus (II) or FWD Life Income Plus more suitable.

This is general information based on CompareFIRST.sg data, not financial advice. Premiums and features can change; please verify with the insurer or a MAS-licensed financial adviser before making any decision.